BioPorto A/S (CPH: BIOPOR)
Denmark
· Delayed Price · Currency is DKK 1.850
-0.016 (-0.86%)
Sep 25, 2024, 4:59 PM CET
BioPorto Company Description
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally.
It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays.
BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
BioPorto A/S
| Country | Denmark |
| Founded | 1917 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 29 |
| CEO | Peter Eriksen |
Contact Details
Address: Tuborg Havnevej 15, st. Hellerup, 2900 Denmark | |
| Phone | 45 45 29 00 00 |
| Website | bioporto.com |
Stock Details
| Ticker Symbol | BIOPOR |
| Exchange | Copenhagen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | DKK |
| ISIN Number | DK0011048619 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Peter Eriksen | Chief Executive Officer |
| Niels Nielsen | Chief Financial Officer |